Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
134,608,103
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
65,465,348
-
Shares change
-
+65,465,348
-
Total reported value, excl. options
-
$844,863,000
-
Value change
-
+$844,863,000
-
Number of buys
-
45
-
Price
-
$12.93
Significant Holders of Tango Therapeutics, Inc. - Common Stock (TNGX) as of Q3 2021
45 filings reported holding TNGX - Tango Therapeutics, Inc. - Common Stock as of Q3 2021.
Tango Therapeutics, Inc. - Common Stock (TNGX) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65,465,348 shares
of 134,608,103 outstanding shares and own 48.63% of the company stock.
Largest 10 shareholders include TRV GP IV, LLC (19,363,975 shares), BOXER CAPITAL, LLC (6,871,642 shares), FMR LLC (6,251,913 shares), Casdin Capital, LLC (5,487,910 shares), HHLR ADVISORS, LTD. (4,373,982 shares), Cormorant Asset Management, LP (3,899,185 shares), Southpoint Capital Advisors LP (3,000,000 shares), RA CAPITAL MANAGEMENT, L.P. (2,250,000 shares), Bain Capital Life Sciences Investors, LLC (1,921,790 shares), and Avoro Capital Advisors LLC (1,550,000 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.